MABRON RETARD 200mg prolonged-release tablets MEDOCHEMIE
Active substance: tramadol
N02AX02 Nervous system | Opioids | Other opioids
Indicated for: moderate to severe pain
Find medicines for human use by name or active substance.
Browse by initial
21–40 of 1,296 medicines
Active substance: tramadol
N02AX02 Nervous system | Opioids | Other opioids
Indicated for: moderate to severe pain
Active substance: tramadol
N02AX02 Nervous system | Opioids | Other opioids
Indicated for: moderate to severe pain
Active substance: rituximab
Indicated for: hematologic malignancies
Active substance: rituximab
Indicated for: hematologic malignancies
Active substance: rituximab
Indicated for: hematologic malignancies
Active substance: rituximab
Indicated for: hematologic malignancies
Active substance: macitentan
Indicated for: pulmonary arterial hypertension
Active substance: macitentan
Indicated for: pulmonary arterial hypertension
Active substance: macitentan
Indicated for: pulmonary arterial hypertension
Active substance: macitentan
Indicated for: pulmonary arterial hypertension
Active substance: nifuratel
Indicated for: mixed vaginal infections
Active substance: pegaptanib sodium
S01LA03 Sensory organs | Ocular vascular disorder agents | Antineovascularisation agents
Indicated for: macular degeneration; diabetic macular edema
Active substance: pegaptanib sodium
S01LA03 Sensory organs | Ocular vascular disorder agents | Antineovascularisation agents
Indicated for: macular degeneration; diabetic macular edema
Active substance: levodopa + benserazide
N04BA02 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
Indicated for: Parkinson's disease
Active substance: levodopa + benserazide
N04BA02 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
Indicated for: Parkinson's disease
Active substance: levodopa + benserazide
N04BA02 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
Indicated for: Parkinson's disease
Active substance: levodopa + benserazide
N04BA02 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
Indicated for: Parkinson's disease
Active substance: levodopa + benserazide
N04BA02 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
Indicated for: Parkinson's disease
WHO (World Health Organization): Any substance or product that is used or is intended to be used to alter a physiological system or a pathological condition in the recipient's benefit.
Medicinal product: A substance or combination of substances used to treat or prevent disease, to restore, correct or modify physiological functions through pharmacological, immunological or metabolic action, or to make a medical diagnosis.
Active ingredient: A substance used in a medicine to produce a pharmacological, immunological or metabolic effect that restores, corrects or modifies physiological functions.
Excipients: Ingredients in a medicine other than its active substance. They can help stabilise the medicine or deliver the active substance to its intended site of action.
Original medicine: A medicine first authorised on the basis of a full dossier documenting its quality, safety and efficacy. It may serve as the reference medicine for a generic product.
Generic medicine: A medicine developed to be equivalent to an authorised reference medicine. It contains the same active substance or substances and is used at the same doses to treat the same diseases. Its inactive ingredients, name, appearance and packaging may differ.